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School of Systems Biology, George Mason University, Manassas, VirginiaABSTRACT All-atom explicit solvent model and replica exchange molecular dynamics were used to investigate binding of
Alzheimer’s biomarker FDDNP to the Ab10–40 monomer. At low and high concentrations, FDDNP binds with high affinity to
two sites in the Ab10–40 monomer located near the central hydrophobic cluster and in the C-terminal. Analysis of ligand-
Ab10–40 interactions at both concentrations identifies hydrophobic effect as a main binding factor. However, with the increase
in ligand concentration the interactions between FDDNP molecules also become important due to strong FDDNP self-aggrega-
tion propensity and few specific binding locations. As a result, FDDNP ligands partially penetrate the core of the Ab10–40 mono-
mer, forming large self-aggregated clusters. Ligand self-aggregation does not affect hydrophobic interactions as a main binding
factor or the location of binding sites in Ab10–40. Using the Ab10–40 conformational ensemble in ligand-free water as reference, we
show that FDDNP induces minor changes in the Ab10–40 secondary structure at two ligand concentrations studied. At the same
time, FDDNP significantly alters the peptide tertiary fold in a concentration-dependent manner by redistributing long-range, side-
chain interactions. We argue that because FDDNP does not change Ab10–40 secondary structure, its antiaggregation effect is
likely to be weak. Our study raises the possibility that FDDNPmay serve as a biomarker of not only Ab fibril species, but of mono-
mers as well.INTRODUCTIONAlzheimer’s disease (AD) is related to the aggregation of Ab
peptides (1,2), which, according to amyloid cascade hypoth-
esis, is responsible for neuronal damage and loss of memory
(3). Spontaneous Ab aggregation is initiated with the oligo-
merization of monomeric polypeptides followed by the
formation of polymorphic amyloid fibrils (4,5). Experi-
mental data indicate that cytotoxicity is mainly determined
by Ab oligomers, even as small as dimers (6,7), whereas the
fibril cytotoxicity is less pronounced (8,9). Definitive AD
diagnosis and the development of disease-modifying thera-
pies are complicated by the lack of reliable in vivo molec-
ular imaging probe, which can detect the formation of Ab
amyloid deposits (10). One of the candidate molecular
probes is a radiofluorinated naproxen derivative FDDNP,
which has been shown to bind in vivo and in vitro to Ab
fibrils (11,12). The structures of tau fragment fibrils com-
plexed with FDDNP ligands resolved recently by x-ray crys-
tallography also suggest a nonspecific binding of the ligand
to these fibrils (13). It is then perhaps not surprising that
FDDNP can label not only AD-related amyloid deposits,
but also other fibrils (e.g., of prions) (14). From a medical
perspective, FDDNP ligand, together with positron emission
tomography, can provide a noninvasive detection and visu-
alization of amyloid deposits in brain tissues (15,16). In
addition, the FDDNP biomarker can be used for evaluation
of AD treatment outcomes and for screening the candidates
for AD drug trials (17).
Although experimental studies have revealed the diag-
nostic utility of FDDNP (15,18), to our knowledge theSubmitted August 16, 2012, and accepted for publication October 3, 2012.
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0006-3495/12/12/2341/11 $2.00molecular mechanisms of FDDNP-Ab interactions are still
poorly understood. It is not clear whether this ligand specif-
ically recognizes fibril deposits, or if could also bind to other
Ab species such as monomers and oligomers; there is no
information on the location and composition of FDDNP
binding sites in Ab species; to serve as a biomarker, FDDNP
should not significantly affect Ab aggregation or change Ab
conformations (however, the validity of this assumption is
unknown as of this writing); and it is important to know
the basic physicochemical factors and interactions which
control FDDNP binding—such information can be of signif-
icant value in the design of new biomarkers with stronger
affinity and better selectivity.
Molecular dynamics (MD) simulations are well posi-
tioned to investigate the questions posed above by mapping
the interactions of Ab species with the ligands at all-atom
resolution (19). In recent years, MD has been used to
explore the mechanisms of fibril growth (20–22) and to
investigate the conformational ensembles of amyloidogenic
monomers (23–25) and oligomers (26–30). More recently,
MD studies have addressed the binding of small molecule
ligands to amyloidogenic peptides (31–34). For example,
binding of aromatic ligands to Ab12–28 fragment has been
investigated with implicit solvent MD (31). No significant
changes in the peptide structural ensemble and no specific
binding sites have been found. Binding of flavonoids to
Ab fibrils has been explored by explicit solvent MD (32).
The results revealed ligand binding to the fibril edges and
their penetration into the fibril hydrophobic core. In our
group, we have initiated the MD studies of the interactions
between Ab peptides and nonsteroidal anti-inflammatory
drugs, ibuprofen and naproxen (35–38). Our studies havehttp://dx.doi.org/10.1016/j.bpj.2012.10.003
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2342 Lockhart and Klimovindicated that these ligands may not only interfere with Ab
aggregation, but also change peptide conformations.
To answer the questions about FDDNP biomarker stated
above, we report in this article the study of FDDNP binding
to Ab monomers probed by all-atom explicit solvent model
and replica exchange molecular dynamics (REMD). We
show that FDDNP binds via hydrophobic interactions to
two Ab sequence regions located near the central hydro-
phobic cluster (CHC) and in the C-terminal. At high ligand
concentration, interligand interactions become also impor-
tant due to strong FDDNP propensity for self-aggregation
comparable with binding to Ab itself. Consequently,
FDDNP ligands partially penetrate the core of the Abmono-
mer, forming large self-aggregated clusters. Comparison
with the Ab conformational ensemble in ligand-free water
shows that FDDNP induces relatively minor changes in
Ab structure, which are limited to the formation of turn
structure near CHC. Comparison of Ab interactions with
the imaging biomarker FDDNP and the anti-aggregation
agent ibuprofen reveals significant differences in the
binding mechanisms of these ligands.FIGURE 1 (a) FDDNP biomarker molecule consists of conjugated
aromatic ring G1, fluoro terminal G2, and dicyano terminal G3. (Green
and blue) Fluorine and nitrogen atoms, respectively. To serve as a tracer
in positron emission tomography scans, FDDNP contains radiofluorinated
18F isotope. (b) Sequence of amino-terminal truncated Ab10–40 peptide.
Following the structure of Ab peptide in the fibril (4), we define N- and
C-termini as sequence regions 10–23 and 29–40. (c) Ab10–40 monomer co-
incubated with 10 FDDNP ligands (in orange). (Light and dark green) Side
chains composing the binding sites BS1 (Phe20, Val24) and BS2 (Ile32,
Leu34, Met35, and Val36) are shown, respectively. (Light gray) The rest of
Ab. For clarity, water is not shown. (See online for colored figure.)METHODS
All-atom explicit solvent model
To represent Ab monomer and FDDNP ligands we used the all-atom
explicit solvent CHARMM22 force field with CMAP corrections (39).
These corrections improve the agreement between experimental and
in silico protein structures in disordered regions (39). Testing the ability
of the CHARMM22 force field to reproduce the Ab monomer conforma-
tional ensemble has been reported in our previous study, which showed
an agreement between in silico and experimental J-coupling constant distri-
butions (40). The parameterization of FDDNP (Fig. 1 a) is described in the
Supporting Material.
Previous experimental (41) and computational (42) studies have demon-
strated that the size distributions and structures of the oligomers formed by
Ab10–40 and the N-terminal truncated fragment Ab10–40 are similar. Further-
more, in the monomeric state the N-terminal of Ab10–40 does not form
extensive long-range interactions or an ordered secondary structure (25).
Consequently, our simulations have been performed for the Ab10–40 peptide
by assuming that it can serve as a model for the full-length Ab10–40
(Fig. 1 b).
We have considered two simulation systems with different concentra-
tions of FDDNP. The first (S1) consisted of the Ab10–40 monomer interact-
ing with 10 FDDNP ligands in the 58.5 A˚  58.5 A˚  58.5 A˚ box
containing 6277 TIP3P water molecules (Fig. 1 c). In S1, the ligand concen-
tration is 80 mM and the ligand/Ab stoichiometric ratio is 10:1. The second
system (S2) was similar to S1 except that it contained only three FDDNP
ligands. In S2, the ligand concentration is 32 mM and the ligand/Ab stoi-
chiometric ratio is 3:1. To neutralize the total charge in each system, one
sodium ion was added. S1 and S2 simulations utilized periodic boundary
conditions. Electrostatic interactions were computed using Ewald summa-
tion, whereas van der Waals interactions were smoothly switched off in the
interval from 8 to 12 A˚. Covalent bonds were constrained by SHAKE algo-
rithm. The ligand/Ab stoichiometric ratios used in our study are within the
range typical for in vitro experiments (from 1:1 to 10:1) (43,44).
Throughout the article, we refer to S1 and S2 as the systems with high
and low ligand concentrations. Control simulations of Ab peptide in
ligand-free water, which were used as reference, have been performed
earlier (40).Biophysical Journal 103(11) 2341–2351Replica exchange molecular dynamics
To sample conformational space of the systems S1 and S2 we used the NVT
replica exchange method (45) coupled with the NAMD MD program (46).
Forty replicas were distributed exponentially in the temperature range from
300 to 440 K. Canonical ensembles in individual replicas were produced by
underdamped Langevin simulations of virtual solvent with the damping
coefficient g ¼ 5 ps1 and the integration step of 1 fs. Exchanges were at-
tempted every 2 ps between all neighboring (along temperature axis)
replicas with the average acceptance rates of 24% (S1) and 29% (S2).
Four (S1) or three (S2) REMD trajectories were produced, resulting in
cumulative simulation times of 3.2 and 2.4 ms, respectively (80 or 60 ns
per replica). The initial segments of REMD trajectories discarded as none-
quilibrated were of 20 (S1) and 4 (S2) ns. The REMD trajectories were
started with random structures of Ab peptide and ligands. Note that the
S2 simulation time is shorter due to faster equilibration and sampling
convergence of this system compared to S1. The REMD convergence and
errors are analyzed in the Supporting Material.
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FIGURE 2 (a) Average numbers of contacts formed by Ab amino acids i
with the ligands, hCl(i)i, are shown (shaded bars). Presented hCl(i)ivalues
are normalized by the maximum value Cl,max. (Dashed line) Threshold
Binding of FDDNP to Ab Peptide 2343Computation of structural probes
To compute molecular interactions we used the following procedure. A
contact between Ab amino acids is formed, if the distance between the
centers of mass of side chains is <6.5 A˚. We chose this cutoff because it
approximately corresponds to the onset of hydration of side chains. FDDNP
molecule can be divided into conjugated aromatic ring (G1), fluoro terminal
(G2), and dicyano terminal (G3) (Fig. 1 a). G1 is hydrophobic, whereas
G2 and G3 have mixed hydrophobic and hydrophilic properties. A contact
with Ab side chain occurs, if the distance between the centers of mass of
the side chain and one of the FDDNP groups is < 6.5 A˚. Two FDDNP
molecules self-aggregate, if any of their G1–G3 centers of mass are within
6.5 A˚ distance. Ligand is assumed bound if it forms at least one contact
with Ab (Fig. 1 c). A ligand is in an extended bound shell if it is not
directly bound to Ab but is included in the cluster of self-aggregated
ligands, which is bound to Ab. Hydrogen bonds between donor (D) and
acceptor (A) atoms exist, if the distance rDA % 3.5 A˚ and : DHA R
120. This definition was applied to detect intrapeptide and Ab-ligand
hydrogen bonds.
Peptide secondary structure was computed by STRIDE (47) and checked
by applying the DSSP program (48; see the Supporting Material). To obtain
solvent accessible surface area (ASA) we used VMD program and took into
account all atoms including hydrogens, setting the probe radius to 1.4 A˚
(49). Hydrophobic accessible surface area (hASA) of amino acid is defined
as a sum of ASAvalues for all apolar atoms in a side chain. Relative hASA
of amino acid X is obtained by dividing the hASA of amino acid X by its
ASA in the reference triplet state (50). Polar accessible surface area
(pASA) of amino acid is the sum of ASA values for all polar atoms in a
side chain. Its relative value is defined in the same way as relative hASA.
The energetics of ligand binding was probed utilizing the NAMDEnergy
module in VMD. Thermodynamic averages of structural quantities
(denoted as h..i) and free energy landscapes were computed using multiple
histogram method (51). The data in the article are reported at 330 K.value (2/3Cl,max) is used to define the ligand binding sites BS1 and BS2.
(Solid circles) Changes in the relative hydrophobic ASA of amino acids i
caused by FDDNP binding, hdhASA(i)i. The average errors in hCl(i)i and
hdhASA(i)i are 5 and 10%. (Inset) Fraction of ligand-Ab interactions attrib-
uted to the largest FDDNP cluster, fc ¼ hCl,c(i)/hCl(i)i, where hCl,c(i)i is the
number of contacts formed by i with the largest cluster of self-aggregated
ligands. (b) Free energy of FDDNP molecule, F(rb), as a function of the
distance to Ab monomer, rb. The states considered as bound (B) and
unbound (U) for computing the free energy of binding are marked (solid
circles). Both panels are computed for high ligand concentration at 330 K.RESULTS
FDDNP binds to Ab monomer
We first present our findings for the S1 system consisting of
Ab monomer and 10 FDDNP ligands. Using REMD, we
computed the average number of bound ligands hLi at
330 K. Because hLi ¼ 6.7 5 0.1, we surmise that the
binding probability for FDDNP molecule Pb is 0.67 5
0.01. Note that Pb only accounts for the ligands directly
bound to Ab, i.e., residing in the first bound shell. If the
ligands residing in the extended bound shell, i.e., bound to
Ab indirectly through other ligands, are included then Pb
increases to 0.90 5 0.04. In what follows, we refer to this
probability as ‘‘extended binding probability’’. To map the
binding affinities of individual amino acids, we have
computed the average number of contacts formed by amino
acid i with the ligands, hCl(i)i. The plot of hCl(i)i shown in
Fig. 2 a demonstrates significant variations in the binding
affinities of amino acids.
To identify binding sites, we assumed that an amino acid
n participates in the binding site, if
hClðiÞi>2
3
Cl;max;
where Cl,max is the maximum value of hCl(i)i for all i. This
definition identifies two binding sites: the first (BS1) is inthe vicinity of the CHC (n ¼ Phe20 and Val24) and the
second (BS2) is in the C-terminal (n ¼ Ile32, Leu34,
Met35, and Val36). All binding amino acids are hydrophobic
and most are located in the C-terminal. This conclusion is
consistent with the computations of the average numbers
of contacts with ligands formed by amino acids in the
N-terminal (0.5 per amino acid) and in the C-terminal (0.9
per amino acid). Interestingly, five charged amino acids
represent the five residues with the weakest affinity for
FDDNP binding—Glu22 (0.08 5 0.01), Glu11 (0.08 5
0.01), Lys16 (0.12 5 0.01), Asp23 (0.13 5 0.02), and
Lys28 (0.175 0.02) (data in parenthesis are hCl(i)i normal-
ized by Cl,max). The total number of contacts between
FDDNP molecules and Ab is 20.2 5 0.4, whereas the
total number of contacts with hydrophobic amino acids is
13.5 5 0 or 67%. In contrast, the average number of
FDDNP-Ab hydrogen bonds is hNlhbi ¼ 0.85 0. Therefore,
FDDNP binding is mostly driven by hydrophobicBiophysical Journal 103(11) 2341–2351
FIGURE 3 Average numbers of ligands hL(Sc)i involved in forming
bound clusters consisting of Sc FDDNP molecules. The plot is obtained
for high ligand concentration at 330 K. (Inset) FDDNP cluster cross-
bridging the binding sites BS1 and BS2 (both in dark green) in the Ab
monomer. (Green, gray, blue, and red) Other hydrophobic, polar, positively
and negatively charged amino acids. (See online for colored figure.)
2344 Lockhart and Klimovinteractions with Ab side chains, whereas FDDNP-Ab
hydrogen bonding does not play significant role.
To further substantiate our conclusions, Fig. 2 a presents
the changes in the relative hydrophobic accessible surface
areas (hASA) of amino acids caused by ligand binding,
hdhASA(i)i. (We define hdhASA(i)i ¼ hhASAb(i)i  hhASAu
(i)i, where hhASAb(i)i and hhASAu(i)i are the hASA of
amino acid i with FDDNP ligands bound or removed.)
The figure displays remarkably strong correlation between
hdhASA(i)i and hCl(i)i (the correlation coefficient is r ¼
0.96). If one considers the absolute values of hASA, then
the average hASA lost due to ligand binding is 28 5 0 A˚2
for hydrophobic residues, 95 1 A˚2 for polar, and 75 1 A˚2
and 3 5 1 A˚2 for positively and negatively charged amino
acids. It is instructive to consider the change in the relative
polar accessible surface areas (pASA) of amino acids caused
by ligand binding, hdpASA(i)i. Fig. S4 in the Supporting
Material reveals that in contrast to hdhASA(i)i, the change
in pASA, hdpASA(i)i, does not correlate with hCl(i)i (r ¼
0.13). These results suggest that hydrophobic effect is the
main driving factor of FDDNP binding.
To investigate the free energy of FDDNP finding, we
computed the free energy of a ligand F(rb) as a function
of the distance to Ab surface rb. In Fig. 2 b, a deep and
wide free energy minimum at rb,min ~ 5 A˚ is associated
with binding to the peptide. The free energy of binding
can be defined as
DFb ¼ Fb  Fu;
where Fb is the bound free energy integrated over the states
with F < F(rb,min) þ 0.3 RT and Fu is the free energy of
unbound state (rb > 18 A˚). Then
Fb ¼ ð4:75 0:3ÞRT and Fu ¼ ð2:55 0ÞRT;
so according to our definition DFb is (2.25 0.3) RT. This
result is consistent with the extended binding probability
Pb¼ 0.90, because F(rb) takes into account all ligands inter-
acting with Ab independent of their exact location in bound
shells. The spatial distribution of FDDNP ligands around
Ab peptide is analyzed in Fig. S5.TABLE 1 Comparison of ligand-ligand and ligand-protein
interactions
System hClpi hClli hElpi, kcal/mol hElli, kcal/mol*
S1 2.05 0.1 3.15 0.1 11.85 0.3 22.05 0.6
S2 3.15 0.1 0.95 0.1 15.65 1.3 6.9 5 1.4
*Energy of interactions of a bound ligand with other ligands.FDDNP self-aggregation
FDDNP ligand is an uncharged hydrophobic molecule, in
which apolar atoms make up ~73% of its solvent accessible
surface area (Fig. 1 a). This property raises the possibility of
ligand self-aggregation during binding. To probe ligand-
ligand interactions we have considered the average numbers
of ligands hL(Sc)i forming bound clusters of the size Sc,
where Sc (R 1) is the number of ligands in the cluster
(Fig. 3). A cluster is considered bound to Ab, if it includes
at least one bound ligand. According to Fig. 3, the number of
ligands in bound clusters is hLci ¼ 95 0.4, of which 8.85
0.3 (or 98%) are included in the clusters of two or moreBiophysical Journal 103(11) 2341–2351molecules (Sc R 2). Therefore, upon binding, the over-
whelming majority of FDDNP ligands self-aggregate.
Because the average number of ligands forming direct inter-
actions with Ab is hLi ¼ 6.7 5 0.1, approximately one-
quarter of all ligands in bound clusters are not in direct
contact with Ab, thereby forming an extended bound shell.
These calculations substantiate the correction to the proba-
bility of binding Pb in the previous section, which shows
that the actual Pb is ~0.90. Strong preference of FDDNP
molecules for self-aggregation also follows from Table 1.
Bound FDDNP ligand, on an average, interacts with two
amino acids (hClpi ¼ 25 0.1), but it forms more than three
contacts with other ligands (hClli ¼ 3.1 5 0.1). Further-
more, the energy of interactions of a bound ligand with other
ligands is hElli ¼ 225 0.6 kcal/mol, whereas the energy
of interactions of a bound ligand with Ab is (hElpi ¼ 11.85
0.3 kcal/mol), i.e., ligand-ligand interactions are approxi-
mately twice stronger than ligand-peptide interactions. To
provide an independent test of FDDNP self-aggregation,
we have performed 30-ns simulations of FDDNP dimer in
water at 330 K. Consistent with the findings for the system
S1, the probability of dimer formation in water is Pla¼ 0.79,
which is even higher than the probability of direct binding to
Ab. Hence, we expect ligand-ligand interactions to be an
important factor in FDDNP binding.
Binding of FDDNP to Ab Peptide 2345Structure of Ab peptide coincubated with FDDNP
ligands
To evaluate the impact of FDDNP binding on Ab structure,
we have used program STRIDE to compute the secondary
structure. Fig. 4 a shows the fractions of turn ht(i)i and helix
hh(i)i structure formed by residues i. Overall, the conforma-
tional ensemble of Ab monomer coincubated with FDDNP
includes turn (hti ¼ 0.57 5 0.01), random coil (hrci ¼
0.32 5 0.01), and helix (hhi ¼ 0.10 5 0) fractions. The
combined fraction of other types of secondary structure is
negligible (0.01). The turn structure dominates the conforma-
tional ensembles in the N- and C-termini (0.655 0.02 and
0.44 5 0.01, respectively), whereas helix appears more
frequently in the C-terminal (0.16 5 0.01 vs. 0.04 5 0 ina
b
FIGURE 4 (a) Distribution of Ab secondary structure: fractions of turn
ht(i)i and helix hh(i)i structure formed by Ab residues i are represented
(squares and circles). (Solid and shaded representation) Data are for high
FDDNP concentration and ligand free water, respectively. The average
errors in ht(i)i and hh(i)i are 4 and 10%. (b) The contact map hC(i, j)i
displays the probabilities of forming contacts between the side chains i
and j (i < j). Local contacts (jijj < 5) are shown above the main diagonal,
i.e., for those j < i. (Circled) Group of contacts between the sequence
regions R1 and R2. All plots are obtained for high ligand concentration
at 330 K. (See online for colored figure.)the N-terminal). The random coil is approximately equally
represented in both termini (0.315 0.01 vs. 0.395 0).
Fig. 4 b presents the average map of Ab side-chain
contacts hC(i, j)i. Analysis of the 16 most-frequent contacts
in Table 2 and visual inspection of Fig. 4 b show that half of
them are related to the long-range (ji – jjR 5) interactions
between the residues His13, His14, Lys16 (R1), and Glu22,
Asp23, Val24 (R2). Importantly, the R1-R2 contacts repre-
sent the most long-range stable interactions in Ab with the
average jj – ij distance of 8.2 (excluding the contacts 14–
19 and 19–24, see Table 2). For comparison, for other
contacts in Table 2 the average jj – ij is 5.3. Although
long-range hC(i, j)i for any specific pair of amino acids is
low (%0.36), the probability that at least one contact is es-
tablished between R1 and R2 is significant (PR1R2 ¼
0.61 5 0.04). The most stable interaction between R1 and
R2 (and across Ab) is the salt bridge forming between
Lys16 and Glu22 (hC(16, 22)iz 0.36). The only other intra-
peptide contact with comparable probability of occurrence
is the salt bridge Asp23-Lys28 (Table 2). The impact of
R1-R2 interaction on the rigidity of Ab backbone is consid-
ered in the Supporting Material.Impact of ligand concentration on binding
mechanism
To investigate the dependence of FDDNP binding on the
ligand/peptide stoichiometric ratio, we have studied the
system S2 with reduced ligand concentration. Using
REMD simulations we have obtained the binding proba-
bility Pb ¼ 0.81 5 0.05, which increases to 0.85 5 0.5 if
the ligands in the extended bound shell are included. As
for S1 the binding affinities of individual amino acids i
were probed by computing the average numbers of contacts
with the ligands, hCl(i)i. Fig. 5 a shows that hCl(i)i is veryTABLE 2 List of the most stable long-range (ji – jjR 5)
intrapeptide contacts in the S1 system
Rank i j hC(i,j)i
1 16 22 0.365 0.06
2 23 28 0.365 0
3 19 24 0.315 0.01*
4 14 23 0.255 0.03
5 35 40 0.255 0
6 14 19 0.255 0.02*
7 24 29 0.205 0.03
8 34 40 0.175 0.04
9 34 39 0.175 0.02
10 14 22 0.175 0.03
11 29 34 0.175 0.05
12 24 31 0.165 0.01
13 16 23 0.155 0.02
14 30 35 0.135 0.03
15 13 22 0.125 0.06
16 13 23 0.125 0.01
Contacts in bold represent the interactions between R1 and R2.
*These two contacts bridge R1 and R2 regions through Phe19.
Biophysical Journal 103(11) 2341–2351
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FIGURE 5 (a) Average numbers of contacts formed by Ab amino acids i
with the ligands, hCl(i)i (shaded bars), in the system with low ligand
concentration. The values of hCl(i)i are normalized by the maximum value
Cl,max. (Dashed line) Threshold value (2/3Cl,max) is used to define the
ligand binding sites BS1 and BS2. (Black circles) Changes in the relative
hydrophobic ASA hdhASA(i)i of amino acids i caused by FDDNP binding.
(Inset) Comparison of hCl(i)i computed for the systems with low (in solid
representation) and high (in shaded representation) FDDNP concentra-
tions. (b) Distribution of the Ab secondary structure is characterized
by the fractions of turn ht(i)i (squares) and helix hh(i)i (circles) structure
formed by residues i. (Solid and shaded representations) Data represent
low FDDNP concentration and ligand free water, respectively. The errors
in panels a and b are similar to those in Figs. 2 a and 4 a. (c) The contact
map hC(i, j)i shows the probabilities of forming contacts between the
side chains i and j at low FDDNP concentration (i < j). Local contacts
(jjij < 5) are shown above the main diagonal, i.e., for those j < i.
(Circled) The group of stable contacts in the C-terminal. (See online for
colored figure.)
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correlation factor between the respective hCl(i)i is 0.88).
Using the same methodology as for S1, we determine
from Fig. 5 a that the FDDNP binding sites are composed
of Phe19, Phe20, and Val24 (BS1) and Leu34, Met35, and
Val36 (BS2). Out of six binding amino acids for the systems
S1 and S2, five are common. All binding amino acids iden-
tified for S2 are hydrophobic and charged amino acids
(Glu22, Glu11, and Lys16) have the lowest binding affinities
in Ab peptide. The number of contacts with ligands hCl(i)i
in Fig. 5 a strongly correlates with the change in the relative
hydrophobic ASA hdhASAb(i)i induced by binding (the
correlation factor is r ¼ 0.96). However, no correlation is
observed between hCl(i)i and the change in the relative polar
ASA hdpASAb(i)i (r¼ 0.10, data not shown). These findings
are consistent with those presented for S1.
There are also important differences between FDDNP
binding in S1 and S2 systems. The inset to Fig. 5 a indicates
that the ligands in S2 form more direct interactions with Ab
than in S1. From the inset we determine that, on an average,
the number of contacts between amino acid and ligands in
S2 is 1.6-times larger than in S1. This observation is consis-
tent with Table 1, which shows that the average number of
contacts with amino acids formed by a ligand hClpi
increases from 2.0 5 0.1 (S1) to 3.1 5 0.1 (S2). Simulta-
neously, there are significantly fewer ligand-ligand contacts
hClli in S2 compared to S1 (0.9 5 0.1 vs. 3.1 5 0.1 in
Table 1). Furthermore, in S2 the average energy of interaction
of a bound FDDNPwithAb is hElpi¼15.65 1.3 kcal/mol,
which is almost 30% lower than hElpi in S1.
However, the average energy of interactions of a bound
ligand with other ligands hElli (¼ 6.9 5 1.4 kcal/mol) is
approximately three-times smaller than in S1 (hElli ¼
22.0 5 0.6 kcal/mol)). Therefore, although the locations
of FDDNP binding sites are largely independent of ligand/
peptide stoichiometry, the ligand concentration does affect
binding energetics—namely, in S1, ligand-ligand interac-
tions make far larger contribution to binding energetics
than direct ligand-peptide interactions. Such large contribu-
tion of ligand-ligand interactions is not observed in S2. The
difference reflects diminished self-aggregation of ligands in
S2. Indeed, the average fraction of bound ligands, which do
not interact with other ligands upon binding, is 0.02 in S1,
but increases to 0.32 in S2. In addition, the fraction of
ligands forming an extended bound shell is just 0.04
compared to 0.23 in S1.
The distribution of secondary structure in Ab peptide co-
incubated with three FDDNP ligands is presented in Fig. 5 b.
The dominant type of structure sampled by Ab is turn (hti ¼
0.54 5 0.01) followed by random coil (hrci ¼ 0.30 5 0)
and helix (hhi ¼ 0.16 5 0.01). The average fractions hti,
hrci, and hhi are similar between S1 and S2, and the compar-
ison of Figs. 4 a and 5 b reveals minor differences in the
local secondary structure propensities. The root-mean-
square deviations (RMSD) for the turn, random coil, and
Binding of FDDNP to Ab Peptide 2347helix structures formed by individual amino acids are 0.16,
0.16, and 0.10, respectively, whereas the combined RMSD
(i.e., the sum of three individual RMSDs) is 0.42. These
calculations suggest that minor differences are observed in
the distributions of turn (due to differing turn propensities
in R1 and 27–31 region) and of random coil (in R1 and
27–34 region; data not shown).
In S1, long-range interactions between R1 and R2 regions
are established (Fig. 4 b). However, comparison of the
contact maps in Figs. 4 b and 5 c suggests that these interac-
tions are largely absent in S2. Out of seven R1-R2 contacts in
Table 2 (note that contacts 14–19 and 19–24 bridging R1 and
R2 through Phe19 are counted as one), only two (salt bridges
Lys16-Glu22 andLys16-Asp23) are also found in the S2 contact
map (Table 3). According to Tables 2 and 3 and visual inspec-
tion of Figs. 4 b and 5 c, most of the long-range interactions in
S2 are shifted to the C-terminal, which participates in the 11
most-probable contacts in S2 (for S1, this number is five). In
general, among 16most-probable intrapeptide contacts in S1
and S2 systems (Tables 2 and 3) there are only seven common
contacts. There are also significant changes in the probabili-
ties of forming individual interactions. For example, the
value of hC (16, 23)i increases from 0.15 5 0.02 (S1) to
0.61 5 0.06 (S2) or hC (30, 35)i changes from 0.13 5
0.03 (S1) to 0.36 5 0.02 (S2). Taken together, it appears
that ligand concentration weakly affects Ab secondary struc-
ture, but it does alter the distribution of tertiary interactions in
Ab monomer.DISCUSSION
Binding mechanism of FDDNP biomarker
Using exhaustive REMD sampling, we have studied binding
of the FDDNP biomarker to the Ab monomer. This ligand
reveals a strong binding propensity, which, when measuredTABLE 3 List of the most stable long-range (ji – jjR 5)
intrapeptide contacts in the S2 system
Rank i j hC(i,j)i
1 16 23 0.615 0.06
2 23 28 0.455 0.05
3 16 22 0.375 0.05
4 30 35 0.365 0.02
5 27 35 0.285 0.02
6 28 34 0.285 0.01
7 19 24 0.245 0
8 35 40 0.195 0
9 33 38 0.175 0.04
10 32 38 0.165 0.03
11 27 34 0.165 0.01
12 34 39 0.145 0.01
13 22 28 0.125 0.03
14 24 36 0.125 0.03
15 32 39 0.115 0.03
16 27 32 0.105 0.01
Contacts in bold are common between S1 and S2 systems.by the binding probability Pb, reaches ~0.90 independent of
the precise value of ligand concentration. Analysis of the
average number of contacts formed by amino acids i with
ligands, hCl(i)i, suggests that the Ab peptide has two
binding sites, the first BS1 located near the CHC and the
second BS2 in the C-terminal. These binding sites are
entirely hydrophobic and composed of largely the same
amino acids at both ligand concentrations (Figs. 2 a and
5 a). We further showed that ligand-Ab interactions strongly
correlate with the change in the relative hydrophobic ASA
hdhASA(i)i induced by binding. At both biomarker concen-
trations the correlation factor between hdhASA(i)i and
hCl(i)i approaches 1.0 (Figs. 2 a and 5 a). It is important
that no correlation is observed between the changes in the
relative polar ASA hdpASA(i)i caused by binding and hCl(i)i
(see Fig. S4). Charged Ab amino acids have the lowest
binding affinities.
Further indication that FDDNP binding is largely driven
by hydrophobic effect follows from the analysis of hydro-
phobicities of Ab side chains involved in the interactions
with ligands. The Ab peptide contains amino acids of 15
types. Using the distribution of hCl(i)i in Fig. 2 a, it is
a straightforward process to obtain the average number of
contacts with ligands formed by amino acid of the type a,
hCl(a)i. Fig. 6 a presents hCl(a)i as a function of the hydro-
phobicities of amino acids a based on Kyte-Doolittle scale,
K(a) (52). This figure demonstrates that amino acids with
higher hydrophobicities tend to form more interactions
with FDDNP. The correlation coefficient of r ¼ 0.82 for
hCl(a)i and K(a) confirms this trend. Similar correlation
(r ¼ 0.73) between hCl(a)i and K(a) is seen when the ligand
concentration is low (system S2).
The correlation between hCl(a)i and amino-acid hydro-
phobicity does not depend appreciably on the specific scale.
For example, if the scales proposed by Rose et al. (50) or Ei-
senberg et al. (53) are used, the respective r values are 0.84 or
0.83 for the system S1. In principle, several FDDNP atoms
including fluorine and nitrogens can serve as hydrogen-
bond acceptors. However, because the number of ligand-
Ab hydrogen bonds is negligible, these interactions appear
to play only minor roles in binding to Ab. Taken together,
our findings suggest that, at high and low ligand concentra-
tions, the main factor governing FDDNP binding is hydro-
phobic effect. This conclusion is consistent with the
fluorescence data showing that bound FDDNP probes tend
to localize in the hydrophobic clefts on the fibril surface (12).
Our study has demonstrated that FDDNP ligands are
characterized by a strong self-aggregation propensity. It
follows from Fig. 3 that at high FDDNP concentration
almost all bound ligands (98%) self-aggregate. According
to Table 1, this propensity is so profound that bound FDDNP
molecules form more interactions with other ligands than
with Ab. As a result, at high concentration, FDDNP ligands
tend to coalesce into large clusters, which cross-bridge the
two binding sites BS1 and BS2 (the inset to Fig. 3). Indeed,Biophysical Journal 103(11) 2341–2351
ab
FIGURE 6 (a) Average number of contacts hCl(a)i formed by amino
acid of the type a with FDDNP ligands as a function of amino-acid hydro-
phobicity K(a) quantified by the Kyte-Doolittle scale. (Straight line) Linear
fit hCl(a)i ¼ b0þ b1K(a) with b0¼ 0.45 and b1¼ 0.07. The plot is obtained
for high ligand concentration at 330 K. (b) The function s(k) measures
correlations in Ab backbone orientation as a function of sequence distance
k between residues. (Solid, shaded, and dashed lines) Data computed
respectively for high FDDNP concentration solution, ligand-free water,
and ibuprofen solution (40).
2348 Lockhart and Klimovthe probability for a single ligand cluster to be bound simul-
taneously to BS1 and BS2 is z0.7.
Furthermore, because almost all ligands are included in the
largest cluster, the interactions between this cluster and Ab
constitute most of the ligand-Ab interactions. The inset to
Fig. 2 a shows the fraction fc of ligand-Ab interactions attrib-
uted to the largest cluster. For all residues, fc > 0.8, with the
average value being equal toz0.91. However, these aspects
of FDDNP binding are concentration-dependent. At low
concentration the binding energetics is dominated by direct
ligand-Ab interactions, whereas ligand-ligand interactions
are far weaker. As evident from Table 1, the number of
ligand-ligand contacts is threefold smaller than the number
of Ab-ligand contacts.
As a result, approximately one-third of all bound ligands
at low concentration are stand-alone molecules forming noBiophysical Journal 103(11) 2341–2351interactions with other ligands. Therefore, ligand self-aggre-
gation makes an important contribution to binding with the
increase in FDDNP concentration, but it does not alter the
main binding factor (hydrophobic effect) or the locations
of binding sites in Ab. It is important to emphasize that
self-aggregation of FDDNP is not merely the consequence
of high ligand concentration, but is determined by FDDNP
hydrophobicity and the existence of specific binding loca-
tions (BS1 and BS2) in Ab peptide, which involve only
19% of its sequence or ~21% of the peptide ASA. The
following estimates for the system S1 illustrate this point.
If the total loss of Ab ASA associated with ligand binding
is z690 A˚2 and the average number of bound ligands is
hLi z 6.7, then the ASA occupied by a single-bound
FDDNP is ~103 A˚2. The total Ab ASA isz3329 A˚2, which
implies that the peptide can accommodate binding of up
32 ligands or of all ligands present in S1, provided that
binding is not residue-specific. Yet, approximately one-
quarter of ligands reside in the extended bound shells
without forming direct interactions with Ab, which is
the consequence of FDDNP hydrophobicity and residue-
specific binding.
We have recently studied the mechanism of ibuprofen
binding to Ab monomer using the system analogous to S1
(40). As FDDNP ibuprofen binding is driven by hydro-
phobic interactions and the ibuprofen binding sites, BS1
(Phe20, Val24) and BS2 (Ala30, Ile32, Leu34, Met35, Val36)
are almost identical to those of FDDNP. This result is
consistent with the experiments, which revealed that
FDDNP and ibuprofen share binding sites in the Ab fibril
(11). However, FDDNP self-aggregation makes this ligand
distinct from ibuprofen, which demonstrates a weak self-
aggregation propensity due to its negative net charge.
One may expect that FDDNP self-aggregation propensity
would play an important role in binding to Ab fibrils. The
experiments of Agdeppa et al. (12) have estimated that the
number of FDDNP binding sites is from 3.5 to 7.1 per
10,000 fibril peptides. Such a small number of binding sites
suggests that most of Ab peptides are buried in the fibril,
leaving only few on its surface available for binding. Given
that a typical in vitro ligand/peptide stoichiometric ratio is
R1, a large local excess of ligands over peptides should
be expected. Then one may argue that binding FDDNP
ligands are likely to self-aggregate on the fibril surface. In
our previous studies of naproxen, which is structurally
similar to FDDNP, we found that it tends to concentrate in
the grooves and indentations on the fibril surface (37).
Following the analogy with naproxen, we propose that
FDDNP ligands display the same tendency. Similar locali-
zation of binding molecules in the fibril hydrophobic
grooves has been observed computationally for thioflavin
T dye and its neutral analog BTA-1 (54).
Finally, it is important to comment on the biological
applicability of our results. Ab peptides in vivo form
a variety of aggregated species, from small oligomers to
Binding of FDDNP to Ab Peptide 2349fibrils. A priori, it is not clear if the modes of FDDNP
binding to these species are similar to those found for the
Ab monomers. Further studies specifically probing the
interactions of FDDNP with Ab oligomers will address
this issue.Does FDDNP binding change Ab structure?
In our previous studies, we have mapped the structural
ensemble of Ab monomer in a ligand-free water environ-
ment (40). Using those REMD simulations, we can assess
the impact of FDDNP binding on Ab structure. We have
shown that the conformational ensemble of Ab monomer
coincubated with 10 FDDNP ligands includes turn (hti z
0.57), random coil (hrci z 0.32), and helix (hhi z 0.10)
structures. The propensity to form turns is especially strong
in the N-terminal (ht(Nt)iz 0.65, Fig. 4 a). Comparisonwith
the secondary structure of Ab in ligand-free water (Fig. 4 a)
indicates that FDDNP somewhat enhances the turn structure
(in water hti z 0.48), especially in the region 12–17
near CHC.
However, Fig. 4 a also demonstrates that excluding this
specific region the fractions of turn, helix, and random
coil (not shown) are remarkably similar for Ab peptides in
ligand-free water and coincubated with FDDNP. Indeed,
the average fractions of helix and random coil in water
(0.13 and 0.38) differ little from those found for FDDNP.
Minor changes in secondary structure induced by FDDNP
are consistent with small changes in the numbers of intra-
peptide hydrogen bonds hNhbi (5.6 in water and 5.2 in
FDDNP solution) and side-chain contacts hCi (26.4 in water
and 24.6 in FDDNP solution), and in the radius of gyration
hRgi (14.7 A˚ in water and 15.5 A˚ in FDDNP solution). The
RMSDs for the turn, random coil, and helix structures are
0.16, 0.15, and 0.05, respectively, with the combined
RMSD of 0.36.
At low FDDNP concentration, the Ab peptide adopts
generally similar (to water) distributions of secondary struc-
ture (Fig. 5 b). Some differences are observed in the turn
propensities within R1 and 27–31 region and in random
coil within R1 and 27–34. The RMSDs for the turn, random
coil, and helix structures are 0.12, 0.12, and 0.07, respec-
tively, and the combined RMSD is 0.31. To put these results
in perspective, we consider the changes in Ab secondary
structure induced by ibuprofen (40). We have shown that
this ligand enhances helix propensity by forming helix-
stabilizing cross-bridges between the amino acids i and
iþ 4. Consequently, the average helix fraction hhi increases
from 0.13 in water to 0.33 in ibuprofen solution, whereas in
the C-terminal region 29–35 hhi rises from 0.25 to 0.74.
With respect to water, the RMSD combined from the turn,
random coil, and helix structures is 0.62 with the individual
RMSDs being equal to 0.18, 0.17, and 0.27. These RMSDs
especially for helix far exceed those computed for both
FDDNP systems.An independent measure of changes in Ab secondary
structure is provided by the autocorrelation function
sðkÞ ¼ ~rðiÞ~rðiþ kÞ;
where ~rðiÞ ¼ ~RCaðiþ 1Þ ~RCaðiÞ is a pseudo backbone
vector and ~RCaðiÞ is the radius vector of the Ca atom in
the residue i. The bar indicates an average taken over i
and Ab structures. The function s(k) measures the correla-
tions in backbone orientation as a function of the distance
k between residues. Fig. 6 b shows that the s(k) values
computed for a high FDDNP concentration system and for
ligand-free water are very similar, but sharply different
from the s(k) value obtained for Ab coincubated with
ibuprofen. Sharp oscillations in s(k) values (e.g., at k ¼ 2
and 4) reflect the formation of helix structures induced by
ibuprofen, which are muted in water or FDDNP solution.
Although FDDNP induces minor change in Ab secondary
structure, it nevertheless alters the peptide tertiary fold. At
high FDDNP concentration, long-range interactions are es-
tablished between R1 and R2 Ab sequence regions, which
are largely absent at low ligand concentration (Figs. 4
b and 5 c and Tables 2 and 3). In the latter case, most long-
range interactions emerge in the C-terminal. Fig. S7 demon-
strates that in ligand-free water, the Ab monomer lacks
long-range interactions either between R1 and R2 or in the
C-terminal, but contains numerous hydrophobic contacts
between the residues near CHC (Phe19, Val24) and in the
C-terminal (Gly29, Ile31, Val34, Met35). The Asp23-Lys28
salt bridge, which is important for Ab fibril stability (4)
and aggregation propensity (55), has low probability of
occurrence in water (hC(i, j)iz 0.17), but is partially formed
at low (0.45) and high (0.36) FDDNP concentrations. There-
fore, in contrast to Ab secondary structure, its tertiary fold
can be modified by FDDNP interactions.
The potential implications of our study are twofold. First,
changes in Ab secondary structure induced by FDDNP are
minor compared to the impact of ibuprofen. Moreover, in
contrast to ibuprofen, FDDNP does not affect helix propen-
sity. Recent experiments have analyzed the impact of 96
ligands on Ab structure and aggregation propensity (44).
These studies have shown that inhibitor ligands generally
increase Ab helix content, while the ligands stimulating
peptide fibrilization tend to enhance b structure. In contrast
to ibuprofen, FDDNP shows neither of these effects and
leaves Ab secondary structure largely unchanged. Then,
FDDNP is expected to be a weak antiaggregation agent, at
least compared to ibuprofen. This tentative conclusion is
important for the following reason. Radiolabeled FDDNP
has a decay half-time of ~2 h. This timescale is sufficiently
long for a ligand to distort Ab equilibrium. For example, in-
vitro experiments have showed that within 2 h, ibuprofen or
naproxen can reduce Ab fibril load up to 50% (43), poten-
tially elevating the concentration of cytotoxic Ab oligomers
(56). However, based on our findings, these concerns do notBiophysical Journal 103(11) 2341–2351
2350 Lockhart and Klimovappear to be pertinent to FDDNP. Second, although the
experiments have demonstrated FDDNP binding to Ab
fibrils (11,43), its interactions with other Ab species have
never been probed. Our study shows that FDDNP ligands
can bind to Abmonomers with high affinity. The possibility
that FDDNP can simultaneously recognize benign mono-
mers and cytotoxic fibrils, which are both found in vivo, rai-
ses the question of selectivity of this biomarker.CONCLUSIONS
We have used all-atom explicit solvent model and replica
exchange molecular dynamics to investigate binding of
FDDNP biomarker to Ab10–40 monomer. The significance
of our results is fourfold. First, we have determined the
mechanism of FDDNP binding to the Ab10–40 monomer.
At low and high concentrations this ligand binds with high
affinity to two sites in the Ab10–40 monomer located near
the central hydrophobic cluster and in the C-terminal. Our
analysis shows that at both concentrations hydrophobic
effect is a main binding factor. However, with the increase
in ligand concentration the interactions between FDDNP
molecules also become important due to the strong FDDNP
self-aggregation propensity and few specific binding loca-
tions. Second, we have probed the impact of FDDNP on
Ab10–40 structure. Taking the Ab10–40 conformational
ensemble in ligand-free water as reference, we showed
that FDDNP induces minor changes in the Ab10–40
secondary structure. At the same time, FDDNP does alter
the peptide tertiary fold by redistributing long-range side-
chain interactions. Third, we argued that, because FDDNP
does not change Ab10–40 secondary structure, it is likely to
be a weaker anti-aggregation agent compared to ibuprofen.
Fourth, our findings and previous experimental studies
demonstrate that FDDNP ligands bind with high affinity
to Ab monomers and fibrils. Consequently, we suggest
that the ability of FDDNP to distinguish cytotoxic fibrils
from benign monomers must be verified in future studies.SUPPORTING MATERIAL
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